BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ImmunoGen, Inc. 

128 Sidney Street

Cambridge  Massachusetts  02139-4239  U.S.A.
Phone: 617-995-2500 Fax: 617-995-2510


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

GlaxoSmithKline (North Carolina) 

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Medarex, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.





 Company News
ImmunoGen, Inc. (IMGN) Announces Conference Call To Discuss Its Fourth Quarter And Fiscal Year 2014 Financial Results 7/18/2014 9:09:25 AM
ImmunoGen, Inc. (IMGN) Announces Preclinical Findings For IMGN779, A Potential Treatment For Acute Myeloid Leukemia 6/16/2014 10:29:24 AM
ImmunoGen, Inc. (IMGN) Announces Favorable STARLYTE Phase II Clinical Data With Sanofi’s SAR3419 In Diffuse Large B-Cell Lymphoma 6/2/2014 9:10:38 AM
ImmunoGen, Inc. (IMGN) Announces Clinical Data Presentations At Upcoming 50th Annual Meeting Of American Society of Clinical Oncology 5/15/2014 9:33:03 AM
ImmunoGen, Inc. (IMGN) Announces Webcast Of Presentations At Upcoming Investor Conferences 5/6/2014 10:21:18 AM
ImmunoGen, Inc. (IMGN) Reports Third Quarter Fiscal Year 2014 Financial Results And Provides Corporate Update 4/25/2014 7:00:39 AM
ImmunoGen, Inc. (IMGN) Announces Conference Call To Discuss Its Third Quarter Fiscal Year 2014 Financial Results 4/18/2014 6:38:45 AM
ImmunoGen, Inc. (IMGN) Announces First Clinical Findings With Refined Dosing Strategy For IMGN853 4/9/2014 9:35:10 AM
ImmunoGen, Inc. (IMGN) Announces Presentations By Company Scientists At Upcoming American Association for Cancer Research Annual Meeting 3/17/2014 10:18:44 AM
ImmunoGen, Inc. (IMGN) Announces Webcast Of Presentations At Upcoming Investor Conferences 2/28/2014 7:20:24 AM
12345678910...